1 documents found
Information × Registration Number 0107U012705, R & D request Title Phase II, randomized, double blind investigation of safety and efficacy of 0.1% and 0.3% ophthalmologic solution of ATG003 compared with placebo in patient with neovascular (wet) age-specific maculardystrophy (HB-MD) Head Сергієнко Микола Маркович, Registration Date 27-12-2007 Organization Shupyk National Medical Academy of Postgraduate Education popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
Phase II, randomized, double blind investigation of safety and efficacy of 0.1% and 0.3% ophthalmologic solution of ATG003 compared with placebo in patient with neovascular (wet) age-specific maculardystrophy (HB-MD)
Head: Сергієнко Микола Маркович. Phase II, randomized, double blind investigation of safety and efficacy of 0.1% and 0.3% ophthalmologic solution of ATG003 compared with placebo in patient with neovascular (wet) age-specific maculardystrophy (HB-MD). Shupyk National Medical Academy of Postgraduate Education. № 0107U012705
1 documents found

Updated: 2026-03-22


Роздрукувати цю сторінку